Related Experiment Video
Updated: Aug 13, 2026

Operation of a Benchtop Bioreactor
Published on: September 12, 2013
Competitive bioreactor hens on the horizon
1Department of Genetics, University of Georgia, Athens, GA 30602-7223, USA. ivarie@uga.edu
Abstract:
The hen has long held promise as a low-cost, high-yield bioreactor for the production of human biopharmaceuticals in egg whites using genetic engineering. Two separate reports have recently appeared indicating the production of substantial levels of human monoclonal and single chain antibodies (>3 mg and >150 mg, respectively) in eggs of transgenic hens. These promising findings indicate that the hen is close to becoming a competitive manufacturing platform for the production of human biopharmaceuticals.
Related Concept Videos
Bioreactor Design and Operational System
Upstream Processing
Bioreactor Controls-II
Bioreactor Controls-I
Bioreactor Controls-III
Designing Growth Media for Bioreactors

